How Much Did Sepragen Raise?
Funding & Key Investors

Sepragen has solidified its position within the life sciences infrastructure sector, securing a total capital infusion of $1.9M. This trajectory of financial backing, punctuated by a recent strategic investment of $700K, underscores the company's critical role in the global biopharmaceutical supply chain. By leveraging debt-based financing, the firm has successfully scaled its operational capacity to meet the rigorous demands of modern drug development and large-scale manufacturing.

The company's financial history reflects a deliberate growth strategy, beginning with initial capital injections in 2020 and culminating in significant debt financing rounds throughout 2024. This consistent influx of resources enables Sepragen to maintain its competitive edge in the high-stakes environment of biological drug production, ensuring that its proprietary chromatography technologies remain at the forefront of industry standards.

What is Sepragen?

Sepragen
ManufacturingTest & Measurement EquipmentBusiness Services

Sepragen operates as a specialized provider of bioprocess chromatography solutions, delivering essential tools for the development and manufacturing of life-saving biological drugs, vaccines, and diagnostics. The company's portfolio encompasses automated chromatography systems, high-performance columns, and specialized resins, complemented by bespoke engineering services. By focusing on the intersection of efficiency and cost-effectiveness, Sepragen serves a diverse clientele spanning the biologics drug manufacturing and health-enhancing human nutrition sectors. Their market position is defined by an ability to streamline complex purification processes, which is a fundamental requirement for companies navigating the transition from laboratory-scale research to commercial-scale production.

How much funding has Sepragen raised?

Sepragen has raised a total of $1.9M across 3 funding rounds:

2020

Debt

$150K

2024

Debt

$1M

Debt

$700K

Debt (2020): $150K with participation from PPP

Debt (2024): $1M, investors not publicly disclosed

Debt (2024): $700K supported by GBC International Bank

Key Investors in Sepragen

GBC International Bank

A financial institution providing specialized commercial banking and debt financing solutions to support industrial growth and capital-intensive projects.

PPP

Public-Private Partnership

Undisclosed Investors

Undisclosed Investors

What's next for Sepragen?

With the recent infusion of capital, Sepragen is well-positioned to accelerate its strategic initiatives in the bioprocessing landscape. The company is expected to prioritize the expansion of its automated systems and the refinement of its resin technology to address the increasing complexity of next-generation biologics. As the demand for rapid vaccine development and advanced therapeutic manufacturing continues to rise, Sepragen's focus will likely shift toward enhancing its customized engineering services to provide turnkey solutions for global pharmaceutical partners. This strategic deployment of resources will be vital in maintaining their trajectory as a key enabler of efficient, scalable, and high-quality biological manufacturing processes.

See full Sepragen company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ElectronicsManufacturing
Building MaterialsManufacturingConstruction ManagementConstruction
ElectronicsManufacturing
ManufacturingPlastic, Packaging & ContainersRetailFlowers, Gifts & Specialty Stores

Frequently Asked Questions Regarding Sepragen Financial Insights

What are the most recent funding rounds that Sepragen has completed, and what were the funding rounds?
Sepragen has recently completed 3 funding rounds: Debt on Dec 31, 2024, Debt on Sep 30, 2024, Debt on Apr 28, 2020.
What is the total amount of funding Sepragen has raised to date?
Sepragen has raised a total of $1.9M in funding to date.
How many funding rounds has Sepragen completed?
Sepragen has completed 3 funding rounds.
How much funding did Sepragen raise in its most recent funding round?
Sepragen raised $700K in its most recent funding round.
Who are the lead investors in Sepragen's latest funding round?
The lead investor in Sepragen's latest funding round was GBC International Bank. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Sepragen's history?
The largest funding round in Sepragen's history was $1M.
See more information about Sepragen